ClinicalTrials.gg
CompletedNCT06538545POSİTİONUpdated Aug 7, 2024

The Effect Of Sitting Position On The Labor Process

An interventional study of Sitting position is used in Experimental Arms 1-2 in Healthy, Bleeding and Pain, sponsored by Cumhuriyet University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-07.

Sponsored by Cumhuriyet University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled May 2022, registered Jul 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
19 Years to 35 Years
Sex
Female
01

Study summary

This study was conducted to determine the effect of sitting position on the labor process. The randomized controlled experimental study was conducted in the delivery room of Sivas Numune Hospital.

02

Conditions studied

  • Healthy
  • Bleeding
  • Pain

Keywords

  • Bleeding
  • pregnant
  • labor duration
  • pain
  • Sitting Position
03

In context

Hemorrhage

3,011 studies on the registry are indexed under Hemorrhage; 466 are open to participants now.

This study's enrollment of 160 is above the median of 100 across 1,990 interventional studies indexed under Hemorrhage.

Browse Hemorrhage studies →

Lead sponsor

Cumhuriyet University is the lead sponsor of 131 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age range: 19-35

    • 38-42 weeks of pregnancy
    • No health problems that would prevent the use of sitting position
    • -Amniotic membranes not ruptured
    • Having a singleton pregnancy
    • Fetus in vertex position
    • Labor occurs with normal spontaneous vaginal delivery
    • No diagnosed chronic physical disease
    • No diagnosed psychiatric disease
    • No risky pregnancy, risky delivery and newborn/fetus
    • No communication problems
    • Voluntarily participating in the research

Exclusion criteria

  • Only women who gave birth at Sivas Sample Hospital were included in the study

    • Women who gave birth more than two times were not included in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Arm 1:Vertical Position (Experimental Group-Primiparous)

    All pregnant women in the experimental group were allowed to use a sitting position (sitting and rocking on a pilates ball or sitting on a bed) from the active phase until labor. They were allowed to lie down for 10-15 minutes when they were tired or when monitoring or intervention was needed.

    Behavioral: Sitting position is used in Experimental Arms 1-2

  • Experimental
    Arm 2: Vertical Position (Experimental Group-Multiparous)

    All pregnant women in the experimental group were allowed to use a sitting position (sitting and rocking on a pilates ball or sitting on a bed) from the active phase until labor. They were allowed to lie down for 10-15 minutes when they were tired or when monitoring or intervention was needed.

    Behavioral: Sitting position is used in Experimental Arms 1-2

  • Active comparator
    Arm 3: Lithotomy Position (Control Group-Primiparous)

    All pregnant women in the control group were followed up with hospital procedures during labor. From the latent phase until labor, the pregnant woman was followed up with hospital procedures. At the end of the latent and active phases, pain assessment was requested and VAS (Appendix 6) was applied. The 2nd and 3rd stages of labor were performed on a normal delivery table in the lithotomy position.

    Behavioral: Sitting position is used in Experimental Arms 1-2

  • Active comparator
    Arm 4: Lithotomy Position (Control Group-multiparous)

    The hospital procedure was applied to determine the birth rates of all pregnant women in the control group. From the latent stage until the birth, the pregnant woman is followed up by applying the hospital procedure. At the end of the latent and active phases, the alarm results were requested to be evaluated and VAS (Appendix 6) was developed. The 2nd and 3rd stages of labor were performed in the lithotomy positions on the normal delivery table.

    Behavioral: Sitting position is used in Experimental Arms 1-2

Interventions

  • BehavioralSitting position is used in Experimental Arms 1-2

    sitting position Comparison of sitting position and lithotomy position in labor

    Also known as: Lithotomy position is used in those with Active Comparison Arm 3-4.

06

What researchers measure

Primary outcomes

  1. Visual analog scale is applied starting from the 1st stage of labor and until the end of the 2nd stage.If the VAS value is 10, it means there is a lot of pain, and if it is 0, it means there is no pain.

    The effect of sitting positions of pregnant women in the 38-42nd weeks of pregnancy on the birth process

    Time frame: 1 years

07

Study locations

2 sites
  • Hilal Güveri
    Sivas, Sivas Merkez 58000, Turkey (Türkiye)
  • Cumhuriyet Üniversitesi
    Sivas, 58000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — Yes: There is a plan to make IPD and related data dictionaries available.

Supporting information: Study protocol

Time frame: 1 years

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2022 to primary completion in Nov 2022, 6 months.

Of 457 non-industry interventional studies with no phase under Hemorrhage, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 40. This study's 6 months is below that.

Counting every sponsor, half of 522 studies reached it within 20 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2024
First posted
Aug 5, 2024
StartActual
May 2, 2022
Primary completionActual
Nov 2, 2022
CompletionActual
Apr 4, 2024
Last update
Aug 7, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06538545
Responsible party
Hilal Guveri (Principal Investigator, Cumhuriyet University) — Principal investigator
First posted
Aug 5, 2024
Start date
May 2, 2022
Primary completion
Nov 2, 2022
Completion
Apr 4, 2024
Last update
Aug 7, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion